M

MetalloBio

6 employees

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.

Basic info

biotechnology research

Biotechnology

Therapeutics

Chemistry

AMR

Antimicrobials

Drug Development

Biopharma

Microbiology

Medical

2021

$331K

from 3 investors over 3 rounds

M

MetalloBio raised $331K on October 1, 2022

Investors: Innovate UK

M

MetalloBio raised $36K on June 29, 2022

Investors: - and Innovate UK